STRATEC SE (SBS.DE) Fundamental Analysis & Valuation

FRA:SBS • DE000STRA555

19.42 EUR
-0.08 (-0.41%)
Last: Mar 9, 2026, 01:34 PM

This SBS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SBS. SBS was compared to 65 industry peers in the Health Care Equipment & Supplies industry. SBS has an average financial health and profitability rating. SBS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. SBS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year SBS was profitable.
  • SBS had a positive operating cash flow in the past year.
  • In the past 5 years SBS has always been profitable.
  • SBS had a positive operating cash flow in each of the past 5 years.
SBS.DE Yearly Net Income VS EBIT VS OCF VS FCFSBS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.72%, SBS is in line with its industry, outperforming 55.38% of the companies in the same industry.
  • SBS has a Return On Equity of 6.67%. This is comparable to the rest of the industry: SBS outperforms 50.77% of its industry peers.
  • SBS has a Return On Invested Capital (5.32%) which is comparable to the rest of the industry.
  • SBS had an Average Return On Invested Capital over the past 3 years of 6.93%. This is below the industry average of 10.72%.
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROIC 5.32%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
SBS.DE Yearly ROA, ROE, ROICSBS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • SBS has a Profit Margin of 6.22%. This is comparable to the rest of the industry: SBS outperforms 50.77% of its industry peers.
  • In the last couple of years the Profit Margin of SBS has declined.
  • SBS has a Operating Margin (10.94%) which is in line with its industry peers.
  • SBS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 29.65%, SBS is doing worse than 86.15% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SBS has grown nicely.
Industry RankSector Rank
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
SBS.DE Yearly Profit, Operating, Gross MarginsSBS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. SBS.DE Health Analysis

2.1 Basic Checks

  • SBS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, SBS has about the same amount of shares outstanding.
  • Compared to 5 years ago, SBS has more shares outstanding
  • SBS has a better debt/assets ratio than last year.
SBS.DE Yearly Shares OutstandingSBS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SBS.DE Yearly Total Debt VS Total AssetsSBS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • SBS has an Altman-Z score of 2.63. This is not the best score and indicates that SBS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.63, SBS perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
  • The Debt to FCF ratio of SBS is 41.27, which is on the high side as it means it would take SBS, 41.27 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SBS (41.27) is worse than 63.08% of its industry peers.
  • SBS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • SBS has a Debt to Equity ratio (0.49) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Altman-Z 2.63
ROIC/WACC0.8
WACC6.67%
SBS.DE Yearly LT Debt VS Equity VS FCFSBS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 4.19 indicates that SBS has no problem at all paying its short term obligations.
  • SBS has a Current ratio of 4.19. This is amongst the best in the industry. SBS outperforms 93.85% of its industry peers.
  • A Quick Ratio of 1.65 indicates that SBS should not have too much problems paying its short term obligations.
  • SBS has a Quick ratio of 1.65. This is in the better half of the industry: SBS outperforms 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 1.65
SBS.DE Yearly Current Assets VS Current LiabilitesSBS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. SBS.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.26% over the past year.
  • The Earnings Per Share has been growing slightly by 2.20% on average over the past years.
  • Looking at the last year, SBS shows a decrease in Revenue. The Revenue has decreased by -4.73% in the last year.
  • The Revenue has been growing slightly by 3.76% on average over the past years.
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%

3.2 Future

  • Based on estimates for the next years, SBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.36% on average per year.
  • The Revenue is expected to grow by 5.51% on average over the next years.
EPS Next Y-11.28%
EPS Next 2Y9.25%
EPS Next 3Y12.63%
EPS Next 5Y12.36%
Revenue Next Year0.4%
Revenue Next 2Y3.61%
Revenue Next 3Y4.89%
Revenue Next 5Y5.51%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBS.DE Yearly Revenue VS EstimatesSBS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
SBS.DE Yearly EPS VS EstimatesSBS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

5

4. SBS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.71, the valuation of SBS can be described as correct.
  • Based on the Price/Earnings ratio, SBS is valued cheaply inside the industry as 95.38% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, SBS is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 10.28, which indicates a very decent valuation of SBS.
  • SBS's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBS is cheaper than 90.77% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SBS to the average of the S&P500 Index (24.60), we can say SBS is valued rather cheaply.
Industry RankSector Rank
PE 14.71
Fwd PE 10.28
SBS.DE Price Earnings VS Forward Price EarningsSBS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBS indicates a rather cheap valuation: SBS is cheaper than 89.23% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBS indicates a slightly more expensive valuation: SBS is more expensive than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 73.7
EV/EBITDA 7.31
SBS.DE Per share dataSBS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • SBS's earnings are expected to grow with 12.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)6.7
EPS Next 2Y9.25%
EPS Next 3Y12.63%

5

5. SBS.DE Dividend Analysis

5.1 Amount

  • SBS has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
  • SBS's Dividend Yield is rather good when compared to the industry average which is at 1.01. SBS pays more dividend than 93.85% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SBS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

  • The dividend of SBS decreases each year by -7.63%.
Dividend Growth(5Y)-7.63%
Div Incr Years0
Div Non Decr Years5
SBS.DE Yearly Dividends per shareSBS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • SBS pays out 45.53% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.53%
EPS Next 2Y9.25%
EPS Next 3Y12.63%
SBS.DE Yearly Income VS Free CF VS DividendSBS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
SBS.DE Dividend Payout.SBS.DE Dividend Payout, showing the Payout Ratio.SBS.DE Dividend Payout.PayoutRetained Earnings

SBS.DE Fundamentals: All Metrics, Ratios and Statistics

STRATEC SE

FRA:SBS (3/9/2026, 1:34:33 PM)

19.42

-0.08 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07
Earnings (Next)N/A
Inst Owners39.05%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap236.15M
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Analysts80
Price Target34.95 (79.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend0.55
Dividend Growth(5Y)-7.63%
DP45.53%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE 14.71
Fwd PE 10.28
P/S 0.92
P/FCF 73.7
P/OCF 10.81
P/B 0.98
P/tB 1.87
EV/EBITDA 7.31
EPS(TTM)1.32
EY6.8%
EPS(NY)1.89
Fwd EY9.73%
FCF(TTM)0.26
FCFY1.36%
OCF(TTM)1.8
OCFY9.25%
SpS21.19
BVpS19.74
TBVpS10.36
PEG (NY)N/A
PEG (5Y)6.7
Graham Number24.22
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROCE 7.38%
ROIC 5.32%
ROICexc 5.68%
ROICexgc 8.34%
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
FCFM 1.24%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
ROICexc(3y)7.69%
ROICexc(5y)10.12%
ROICexgc(3y)11.48%
ROICexgc(5y)16.01%
ROCE(3y)9.61%
ROCE(5y)11.28%
ROICexgc growth 3Y-26.1%
ROICexgc growth 5Y2.82%
ROICexc growth 3Y-25.31%
ROICexc growth 5Y3.93%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Debt/EBITDA 2.49
Cap/Depr 99.05%
Cap/Sales 7.24%
Interest Coverage 5.44
Cash Conversion 46.48%
Profit Quality 20%
Current Ratio 4.19
Quick Ratio 1.65
Altman-Z 2.63
F-Score7
WACC6.67%
ROIC/WACC0.8
Cap/Depr(3y)101.4%
Cap/Depr(5y)105.66%
Cap/Sales(3y)6.8%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
EPS Next Y-11.28%
EPS Next 2Y9.25%
EPS Next 3Y12.63%
EPS Next 5Y12.36%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%
Revenue Next Year0.4%
Revenue Next 2Y3.61%
Revenue Next 3Y4.89%
Revenue Next 5Y5.51%
EBIT growth 1Y-3.3%
EBIT growth 3Y-17.64%
EBIT growth 5Y9.13%
EBIT Next Year46.16%
EBIT Next 3Y26.35%
EBIT Next 5Y18.35%
FCF growth 1Y114.46%
FCF growth 3Y-10.96%
FCF growth 5YN/A
OCF growth 1Y1784.43%
OCF growth 3Y-8.44%
OCF growth 5Y18.03%

STRATEC SE / SBS.DE FAQ

Can you provide the ChartMill fundamental rating for STRATEC SE?

ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE.


What is the valuation status for SBS stock?

ChartMill assigns a valuation rating of 5 / 10 to STRATEC SE (SBS.DE). This can be considered as Fairly Valued.


How profitable is STRATEC SE (SBS.DE) stock?

STRATEC SE (SBS.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for SBS stock?

The financial health rating of STRATEC SE (SBS.DE) is 5 / 10.


Can you provide the expected EPS growth for SBS stock?

The Earnings per Share (EPS) of STRATEC SE (SBS.DE) is expected to decline by -11.28% in the next year.